Table 2.
Samples | Statistics (between Groups) | ||||||
---|---|---|---|---|---|---|---|
Whole sample | Early onset of MS (EOMS) |
Adult onset of MS (AOMS) |
Late onset of MS (LOMS) |
Post-hoc tests | |||
N | 2627 | 127 | 2416 | 84 | |||
n (%) | n (%) | n (%) | n (%) | ||||
Autoimmune comorbidity (yes vs. no) | 440 (16.7%) | 31 (24.4%) | 402 (16.6%) | 7 (8.3%) | X2(N = 440, df = 2) = 3.42 | ||
MS familial history | First degree (yes vs. no) | 250 (9.5%) | 15 (11.8%) | 227 (9.4%) | 8 (9.5%) | X2(N = 632, df = 3) = 2.45 | |
Second degree (yes vs. no) | 382 (14.5%) | 14 (11.0%) | 362 (15.0%) | 6 (7.1%) | |||
Family history of other autoimmune disorder (first degree) (yes vs. no) |
125 (4.8%) | 4 (3.1%) | 115 (4.8%) | 6 (7.1%) | X2(N = 125, df = 1) = 1.95 | ||
Current disease course | Relapsing remitting MS | 2129 (81.0%) | 109 (85.8%) | 1971 (81.6%) | 49 (58.3%) | X2(N = 2627, df = 4) = 71.83 *** | |
Secondary progressive MS | 415 (15.8%) | 18 (14.2%) | 377 (15.6) | 20 (23.8%) | POMS: more RRMS, less SPMS, low PPMS AOMS: more LOMS: more sPMS and PPMS |
||
Primary progressive MS | 83 (3.2%) | - | 68 (2.8%) | 15 (17.9%) | |||
Number of patients with relapse in the first two years | 0/1/2/3 | 1981/508/122/16 | 81/32/14/0 | 1831/463/106/16 | 69/13/2/0 | X2(N = 2627, df = 6) = 19.57 *** | POMS: 1 and 2 relapses AOMS: zero and 3 relapsaes LOMS: 0 relapses |
Median (range) | Median (range) | Median (range) | Median (range) | ||||
EDSS at first visit | 2.0 (1.0–2.5) | 2.0 (0.0–2.0) | 2.0 (1.0–2.5) | 2.25 (2.0–3.0) | H(N = 2608, df = 2) = 31.38 *** | LOMS > POMS; AOMS | |
EDSS at last follow-up | 1.0 (0.0–2.5) | 0.0 (0.0–2.0) | 1.0 (0.0–2.5) | 2.25 (0.75–5.0) | H(N = 2608, df = 2) = 27.69 *** | LOMS > POMS; AOMS | |
First inter-attack interval (years) | 3.0 (1.0–5.0) | 2.0 (1.0–4.0) | 3.0 (1.0–5.0) | 2.0 (1.0–5.0) | H(N = 2608, df = 2) = 4.54 | ||
n (%) | n (%) | n (%) | n (%) | ||||
Prevalent symptoms at onset | Sensory | 786 (29.9%) | 19 (15.0%) | 741 (30.7%) | 26 (31.0%) | X2(N = 2627, df = 10) = 70.75 *** | |
Visual | 688 (26.2%) | 45 (35.4%) | 632 (26.2%) | 11 (13.1%) | |||
Motor | 417 (15.9%) | 19 (15.0%) | 366 (15.1%) | 32 (38.1%) | POMS: visual ; brain stem ; other | ||
Brainstem | 299 (11.4%) | 21 (16.5%) | 277 (11.5%) | 1 (1.2%) | AOM: sensory LOMS: motor celebellar ; visual |
||
Cerebellar | 161 (6.1%) | 3 (2.4%) | 148 (6.1%) | 10 (11.9%) | |||
Others | 97 (3.7%) | 6 (4.7%) | 90 (3.7%) | 1 (1.2%) | |||
Disease modifying treatments at the last visit | First line | 1709 (65.1%) | 63 (49.6%) | 1585 (65.6%) | 61 (72.6%) | X2(N = 2627, df = 4) = 28.14 *** | POMS: first ; second ; switch |
Second/third line | 918 (34.9%) | 64 (50.4%) | 831 (34.4%) | 23 (27.4%) | AOMS: first | ||
switch | LOMS first ; second |
Notes: *** = p < 0.001. = higher than; = lower than.